Islet alpha-cells do not influence insulin secretion from beta-cells through cell-cell contact.
Interactions between the endocrine cells in islets of Langerhans influence their secretory function, and disruption of islet structure results in impaired insulin secretory responses to both nutrient and non-nutrient stimuli. We have previously demonstrated that insulin-secreting MIN6 cells show enhanced secretory responses when grown as islet-like structures (pseudoislets) suggesting that homotypic cell-cell interactions between beta-cells are important for normal function. We have now extended this experimental model to study the role of heterotypic interactions between insulin-expressing and glucagon-expressing cells by measuring the organization and secretory function of pseudoislets formed from MIN6 and alphaTC1 cells. The direct alpha-cell to beta-cell contact in the heterogenous MIN6/alphaTC1 pseudoislets was sufficient to enable the formation of anatomically correct islet-like structures, with a central core of MIN6 cells surrounded by a periphery of alphaTC1 cells. However, the presence of alphaTC1 cells had no detectable effect on insulin secretory responses to nutrient or non-nutrient stimuli. In contrast, exogenous glucagon enhanced insulin secretion, in accordance with a paracrine role for alpha-cell-derived glucagon in the regulation of insulin secretion rather than direct, contact-mediated effects of alpha-cells on neighbouring beta-cells.
Brereton
Helen
H
Beta Cell Development and Function Group, Division of Reproduction and Endocrinology, GKT School of Biomedical and Health Sciences, King's College London, Guy's Campus, London, SE1 1UL, UK.
Carvell
Melanie J
MJ
Persaud
Shanta J
SJ
Jones
Peter M
PM
D000818:Animals; D018929:Cell Culture Techniques; D002460:Cell Line; D005934:Glucagon / Q000378:metabolism; D050416:Glucagon-Secreting Cells / Q000378:metabolism / Q000502:physiology*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000378:metabolism / Q000502:physiology*; D051379:Mice
D007328:Insulin; D005934:Glucagon
Proc Natl Acad Sci U S A. 1982 Dec;79(23):7322-5
6760195
Diabetes. 2002 Jan;51(1):98-104
11756328
Pflugers Arch. 1997 Sep;434(5):515-24
9242714
Diabetes. 2004 Apr;53(4):1038-45
15047619
J Clin Invest. 1995 Nov;96(5):2496-502
7593640
Endocrinology. 1985 Nov;117(5):2073-80
2864239
Mol Cell Endocrinol. 2002 Jun 14;191(2):167-76
12062900
J Mol Endocrinol. 1988 Sep;1(2):105-10
2855589
Biochem Biophys Res Commun. 2006 Apr 28;343(1):99-104
16529716
Endocrinology. 1991 Nov;129(5):2409-14
1682135
J Clin Invest. 1975 Oct;56(4):1066-70
1099118
Diabetes. 2005 Jun;54(6):1808-15
15919803
J Clin Invest. 1982 Feb;69(2):405-13
6173398
Cell Calcium. 2002 May;31(5):209-19
12098223
Diabetes. 1996 Apr;45(4):385-92
8603757
Biochem Biophys Res Commun. 2006 Jun 9;344(3):995-1000
16643853
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2334-9
16461897
J Clin Endocrinol Metab. 1975 Nov;41(5):841-4
1102552
Experientia. 1973 Aug 15;29(8):1015-8
4582082
Exp Biol Med (Maywood). 2003 Nov;228(10):1227-33
14610265
J Cell Sci. 1994 Jun;107 ( Pt 6):1429-36
7962186
Diabetes. 1999 Jul;48(7):1402-8
10389845
Development. 1996 Sep;122(9):2895-902
8787762
Nat Cell Biol. 2003 Apr;5(4):330-5
12640462
Endocrinology. 1985 Sep;117(3):824-33
2862021
J Cell Biol. 1999 Jan 25;144(2):325-37
9922458
Diabetes. 2002 Jan;51(1):114-23
11756330
Biochem J. 1988 Sep 1;254(2):397-403
2845950
Lancet. 1975 Dec 20;2(7947):1243-4
53729
Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E502-9
15479950
Dev Biol. 1991 Nov;148(1):233-42
1936561
Endocrinology. 1982 Jul;111(1):86-94
6123433
Exp Cell Res. 1990 Dec;191(2):305-12
2257882
Endocrinology. 1990 Jul;127(1):126-32
2163307
Diabetes. 1987 Jul;36(7):783-90
3556277